
Please try another search
Investing.com - Citi analysts increased their price target from $210 to $229 on Salesforce Inc (NYSE:CRM) and maintained a neutral rating despite mixed performance during the quarter.
While there is limited upside to top-line numbers for the fiscal year due to macroeconomic uncertainty and 'Salesforce fatigue', the analysts see greater potential on the margin front.
Citi's checks with Salesforce partners revealed a resilient federal deal pipeline and strength in its Marketing Cloud service, offset by challenges such as slow decision-making, renewal pressure, and customer optimization efforts.
While full-year revenue guidance raises are expected to be limited, Citi analysts have increased their margin estimates due to stronger expected cost savings from recent workforce reductions.
This article was produced with assistance from artificial intelligence.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.